ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 47 filers reported holding ZAI LAB LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 106,171 | $2,938 | 14.16% |
| Genesis Investment Management, LLP | 1,352,222 | $37,420,559 | 4.06% |
| Segantii Capital Management Ltd | 1,795,479 | $49,788,633 | 2.59% |
| HSG Holding Ltd | 694,634 | $19,262,201 | 2.20% |
| Paradigm Biocapital Advisors LP | 865,297 | $23,994,686 | 1.85% |
| INDUS CAPITAL PARTNERS, LLC | 25,256 | $700,349 | 1.41% |
| Privium Fund Management B.V. | 240,683 | $6,366,065 | 1.34% |
| Vivo Capital, LLC | 445,505 | $12,353,854 | 0.85% |
| Rock Springs Capital Management LP | 1,222,423 | $33,897,790 | 0.81% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $2,189,505 | 0.67% |